This afternoon, I received an email that Medtronic has just sent out a press release regarding the ASPIRE study – the one where the worlds first insulin pump with LGS (Low-Glucose Suspend)! Results are awesome, too! According to the information, there was a 19% reduction in time spent below 70 when users were on this pump system. That is awesome, folks. A huge step in the right direction, in my opinion.
While it isn’t a cure, I do applaud these people who are working so hard to get better technology like this for us so that we can hopefully live longer, better lives, and maybe reduce the number of blue candles lit for lives lost due to hypoglycemia. And also, a huge thanks to those who are in the study, being human lab-rats for us.
🙂
If you’d like to read the release, you can find it HERE.
Sugabetic 
This is a great update and awesome news, indeed! Thanks for getting word out, Sarah! Hope all is well on your end, my friend.
I’m starting this study in about a month. I am REALLY hoping that I am NOT in the control group!
This is great news that it hopefully will make it to the US soon for us to use. It has been in Europe for quite some time so it is old news to them. FDA is very slow of course because so many people sue.